Up to Date Hepatology Course , Romania

24/08/2026

NEW MULTIDISCIPLINARY PAPER SETS OUT A NATIONAL ROADMAP FOR MASLD IN ROMANIA

Experts call for targeted fibrosis case-finding, a country-specific referral pathway, an integrated multidisciplinary model of care, and the implementation of a National MASLD Action Plan.
We are pleased to share a new multidisciplinary Position Paper on metabolic dysfunction-associated steatotic liver disease (MASLD) in Romania, initiated and coordinated by Prof. Liana Gheorghe, co-authored by Prof. Jeffrey V. Lazarus, and developed with the contribution of remarkable national and international experts in the field. The paper has been accepted for publication in the Journal of Gastrointestinal and Liver Diseases.

Entitled “Metabolic Dysfunction-associated Steatotic Liver Disease in Romania: A Multidisciplinary Position Paper on Prevalence, Clinical Spectrum, Prevention, Screening and Management,” the paper brings together scientific evidence, Romanian estimates, the 2024 EASL–EASD–EASO recommendations, and health policy perspectives to formulate ten consensus recommendations for action.

With approximately 5 million Romanian adults — an estimated 30–33% of the adult population — potentially affected by MASLD, the paper highlights the urgent need to identify patients at risk of fibrosis progression and to act before advanced liver disease develops.

The proposed roadmap calls for targeted fibrosis case-finding, a country-specific clinical care pathway, an integrated multidisciplinary model of care, and the development of a National MASLD Action Plan — translating scientific consensus into concrete national action.

Several of these principles are already being translated into practice through LIVE(RO)4, creating a direct link between scientific consensus and real-world implementation in prevention, screening, early diagnosis, risk stratification, and access to care.

The central message is clear: advanced liver disease is not inevitable. Identifying fibrosis before cirrhosis and hepatocellular carcinoma develop is increasingly a matter of organisation and implementation, not of technology.

We are proud of this important collaborative achievement and deeply grateful to all national and international experts whose expertise, commitment, and multidisciplinary collaboration made this work possible.




https://www.roald.ro/stiri/newsletter/new-multidisciplinary-paper-sets-out-a-national-roadmap-for-masld-in-romania

11/04/2026

09/04/2026

March Monthly Insights - RoALD

March was a month of science, collaboration and meaningful patient voices in liver care.

RoALD brought together two major annual events in Bucharest:
the 3rd Romanian Forum of Metabolic Hepatology and the 13th Update on Hepatology Course - both centered on earlier recognition, better risk stratification, multidisciplinary care and a stronger long-term vision for liver health.

A special highlight of the month was also HepaHUB: Connecting with Our Patients, reminding us that modern hepatology is not only about treating disease, but also about listening to the patient voice.

March also brought important international updates through Baveno VIII, with new insights into portal hypertension, cirrhosis, dynamic risk assessment and prevention of decompensation as well as recompensation.

Thank you to all our speakers, collaborators, patients and participants who made this month so meaningful.

16/03/2026

Dorim, de asemenea, să ne exprimăm sincera recunoștință față de pacienții cu boli hepatice cronice și pacienții transplantați hepatic care au participat la întâlnirea „HepaHUB: Connecting with Our Patients – Your Health, Your Voice: Patient-Reported Outcomes in Liver Care”.

Prezența lor, deschiderea și curajul de a-și împărtăși poveștile personale au oferit un sens profund și o valoare reală acestei discuții importante. Prin faptul că și-au adus vocea și experiența trăită în prim-plan, ei ne ajută să înțelegem mai bine nevoile și prioritățile pacienților și să ne îmbunătățim abordarea clinică prin integrarea măsurilor raportate de pacient privind rezultatele (PROMs) și a măsurilor raportate de pacient privind experiența îngrijirii (PREMs) în practica hepatologică.

Contribuția lor a fost neprețuită și le suntem profund recunoscători pentru încrederea și implicarea lor.

14/03/2026